Atlas Trials

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

Clinical trial NCT00352846 · COMPLETED

Trial details

NCT number
NCT00352846
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaLymphoma
Start date
2006-01-01
Primary completion
2011-09-01
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.